| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 45 | 2023 | 2529 | 4.520 |
Why?
|
| Soft Tissue Neoplasms | 38 | 2023 | 1363 | 4.080 |
Why?
|
| Chordoma | 26 | 2023 | 359 | 3.950 |
Why?
|
| Sarcoma | 40 | 2023 | 1897 | 3.830 |
Why?
|
| Chondrosarcoma | 9 | 2023 | 309 | 2.270 |
Why?
|
| Liposarcoma | 7 | 2020 | 333 | 2.000 |
Why?
|
| RNA-Binding Protein EWS | 13 | 2023 | 216 | 1.970 |
Why?
|
| Osteosarcoma | 14 | 2022 | 881 | 1.870 |
Why?
|
| Giant Cell Tumor of Bone | 8 | 2022 | 116 | 1.820 |
Why?
|
| Bone Cysts, Aneurysmal | 3 | 2022 | 73 | 1.770 |
Why?
|
| Chondroblastoma | 6 | 2020 | 50 | 1.650 |
Why?
|
| Rhabdomyosarcoma | 5 | 2022 | 382 | 1.580 |
Why?
|
| Fibrosarcoma | 5 | 2023 | 348 | 1.530 |
Why?
|
| Myoepithelioma | 4 | 2019 | 43 | 1.360 |
Why?
|
| Lipoma | 6 | 2020 | 334 | 1.280 |
Why?
|
| Gene Fusion | 7 | 2022 | 371 | 1.280 |
Why?
|
| Vulvar Neoplasms | 9 | 2022 | 272 | 1.280 |
Why?
|
| Chondroma | 4 | 2020 | 58 | 1.190 |
Why?
|
| Osteoblastoma | 2 | 2022 | 24 | 1.140 |
Why?
|
| Joint Diseases | 3 | 2021 | 480 | 1.010 |
Why?
|
| Uterine Neoplasms | 7 | 2023 | 1513 | 1.000 |
Why?
|
| Cell Dedifferentiation | 3 | 2020 | 135 | 0.910 |
Why?
|
| Immunohistochemistry | 47 | 2022 | 11366 | 0.910 |
Why?
|
| Spinal Neoplasms | 11 | 2018 | 760 | 0.900 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2020 | 380 | 0.890 |
Why?
|
| Pelvic Neoplasms | 2 | 2022 | 254 | 0.850 |
Why?
|
| NFATC Transcription Factors | 2 | 2021 | 381 | 0.810 |
Why?
|
| Bone Cysts | 1 | 2021 | 47 | 0.780 |
Why?
|
| Knee Joint | 4 | 2018 | 1680 | 0.740 |
Why?
|
| Sarcoma, Clear Cell | 3 | 2022 | 76 | 0.740 |
Why?
|
| Epithelioid Cells | 5 | 2020 | 71 | 0.720 |
Why?
|
| Hemangiosarcoma | 7 | 2023 | 239 | 0.710 |
Why?
|
| In Situ Hybridization | 3 | 2020 | 1950 | 0.700 |
Why?
|
| Neurofibrosarcoma | 1 | 2019 | 24 | 0.700 |
Why?
|
| Gene Rearrangement | 8 | 2021 | 1179 | 0.690 |
Why?
|
| Humerus | 2 | 2021 | 266 | 0.680 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 350 | 0.670 |
Why?
|
| Leiomyosarcoma | 4 | 2022 | 477 | 0.670 |
Why?
|
| Sarcoma, Synovial | 6 | 2023 | 167 | 0.670 |
Why?
|
| Fibula | 1 | 2021 | 269 | 0.650 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 449 | 0.640 |
Why?
|
| Myxoma | 3 | 2013 | 130 | 0.640 |
Why?
|
| Mucin-4 | 2 | 2014 | 37 | 0.640 |
Why?
|
| Synovial Cyst | 1 | 2018 | 35 | 0.630 |
Why?
|
| In Situ Hybridization, Fluorescence | 14 | 2023 | 2649 | 0.620 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 6 | 2014 | 705 | 0.600 |
Why?
|
| Middle Aged | 117 | 2023 | 213383 | 0.560 |
Why?
|
| Neoplasms, Radiation-Induced | 4 | 2019 | 547 | 0.540 |
Why?
|
| Carcinoma | 3 | 2021 | 2375 | 0.540 |
Why?
|
| Diagnosis, Differential | 28 | 2022 | 12959 | 0.540 |
Why?
|
| Spine | 3 | 2018 | 1144 | 0.530 |
Why?
|
| Cell Differentiation | 12 | 2023 | 11483 | 0.530 |
Why?
|
| Female | 143 | 2023 | 380194 | 0.520 |
Why?
|
| Adult | 120 | 2023 | 214055 | 0.520 |
Why?
|
| Humans | 210 | 2023 | 744343 | 0.500 |
Why?
|
| Femur | 2 | 2021 | 1297 | 0.500 |
Why?
|
| S100 Proteins | 8 | 2022 | 259 | 0.490 |
Why?
|
| Fibroma | 4 | 2018 | 212 | 0.490 |
Why?
|
| Calmodulin-Binding Proteins | 6 | 2019 | 249 | 0.490 |
Why?
|
| Sacrum | 4 | 2018 | 288 | 0.480 |
Why?
|
| Neoplasm Recurrence, Local | 18 | 2023 | 9239 | 0.480 |
Why?
|
| Meningeal Neoplasms | 2 | 2022 | 1241 | 0.470 |
Why?
|
| Extremities | 9 | 2014 | 865 | 0.470 |
Why?
|
| Male | 135 | 2023 | 350118 | 0.470 |
Why?
|
| Synovial Membrane | 3 | 2018 | 507 | 0.470 |
Why?
|
| Aged | 89 | 2023 | 163280 | 0.470 |
Why?
|
| Nerve Sheath Neoplasms | 6 | 2021 | 190 | 0.460 |
Why?
|
| Hemangioma | 3 | 2023 | 738 | 0.460 |
Why?
|
| Meningioma | 2 | 2022 | 1209 | 0.450 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2015 | 736 | 0.440 |
Why?
|
| Bone Diseases | 2 | 2021 | 416 | 0.430 |
Why?
|
| Young Adult | 47 | 2023 | 56430 | 0.420 |
Why?
|
| Mutation | 15 | 2023 | 29786 | 0.410 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 180 | 0.410 |
Why?
|
| Keratins | 5 | 2010 | 515 | 0.400 |
Why?
|
| Oncogene Fusion | 3 | 2020 | 99 | 0.390 |
Why?
|
| Hashimoto Disease | 1 | 2012 | 97 | 0.390 |
Why?
|
| Sciatic Nerve | 1 | 2014 | 607 | 0.390 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2007 | 234 | 0.370 |
Why?
|
| Histiocytosis, Sinus | 1 | 2010 | 47 | 0.370 |
Why?
|
| Polyethylenes | 3 | 2018 | 285 | 0.370 |
Why?
|
| RNA-Binding Protein FUS | 3 | 2020 | 72 | 0.370 |
Why?
|
| Giant Cell Tumors | 4 | 2015 | 99 | 0.370 |
Why?
|
| Genital Neoplasms, Female | 3 | 2022 | 523 | 0.360 |
Why?
|
| Oncogene Proteins, Fusion | 8 | 2023 | 1581 | 0.360 |
Why?
|
| Neurilemmoma | 4 | 2021 | 547 | 0.360 |
Why?
|
| Plasma Cells | 2 | 2012 | 591 | 0.350 |
Why?
|
| Transcription Factors | 8 | 2021 | 12208 | 0.340 |
Why?
|
| Adolescent | 50 | 2023 | 85781 | 0.340 |
Why?
|
| Osteoma, Osteoid | 2 | 2007 | 80 | 0.340 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2010 | 143 | 0.330 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3597 | 0.330 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2010 | 105 | 0.320 |
Why?
|
| Ovarian Neoplasms | 6 | 2019 | 4838 | 0.320 |
Why?
|
| Sarcoma, Small Cell | 2 | 2022 | 22 | 0.320 |
Why?
|
| Thyroid Gland | 2 | 2012 | 1173 | 0.320 |
Why?
|
| Aged, 80 and over | 36 | 2021 | 57776 | 0.310 |
Why?
|
| Skull | 2 | 2014 | 813 | 0.310 |
Why?
|
| Mandibular Neoplasms | 2 | 2010 | 129 | 0.310 |
Why?
|
| Neurofibromatosis 1 | 4 | 2019 | 569 | 0.310 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2019 | 496 | 0.300 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 871 | 0.300 |
Why?
|
| Prognosis | 21 | 2023 | 29063 | 0.300 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 2 | 2018 | 75 | 0.300 |
Why?
|
| Angiomyoma | 2 | 1997 | 12 | 0.300 |
Why?
|
| Actins | 7 | 2020 | 2121 | 0.290 |
Why?
|
| Disease-Free Survival | 8 | 2023 | 6895 | 0.290 |
Why?
|
| Nose Neoplasms | 1 | 2009 | 246 | 0.280 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 3 | 2014 | 105 | 0.280 |
Why?
|
| Desmin | 4 | 2020 | 130 | 0.280 |
Why?
|
| DNA-Binding Proteins | 6 | 2022 | 9648 | 0.270 |
Why?
|
| Solitary Fibrous Tumors | 2 | 2022 | 72 | 0.270 |
Why?
|
| Translocation, Genetic | 5 | 2019 | 1420 | 0.270 |
Why?
|
| Immunoglobulin G | 3 | 2012 | 4560 | 0.260 |
Why?
|
| Pathology, Clinical | 2 | 2022 | 368 | 0.260 |
Why?
|
| Skull Base Neoplasms | 3 | 2023 | 284 | 0.260 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 2018 | 102 | 0.260 |
Why?
|
| Collagen | 5 | 2010 | 2689 | 0.260 |
Why?
|
| Sarcoma, Alveolar Soft Part | 2 | 2014 | 41 | 0.250 |
Why?
|
| Notochord | 3 | 2023 | 36 | 0.250 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2005 | 45 | 0.250 |
Why?
|
| Retroperitoneal Neoplasms | 5 | 2010 | 340 | 0.250 |
Why?
|
| Liposarcoma, Myxoid | 3 | 2014 | 67 | 0.250 |
Why?
|
| Biopsy | 12 | 2022 | 6756 | 0.250 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 2282 | 0.240 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 6364 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2016 | 2942 | 0.240 |
Why?
|
| Gene Deletion | 4 | 2019 | 2751 | 0.240 |
Why?
|
| RNA-Binding Proteins | 4 | 2014 | 1903 | 0.230 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 2043 | 0.230 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2017 | 604 | 0.230 |
Why?
|
| Thoracic Vertebrae | 3 | 2018 | 608 | 0.230 |
Why?
|
| Carcinoma, Papillary | 3 | 2015 | 783 | 0.230 |
Why?
|
| Hemangiopericytoma | 3 | 2008 | 77 | 0.220 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2021 | 4554 | 0.220 |
Why?
|
| Neoadjuvant Therapy | 5 | 2022 | 2728 | 0.220 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2017 | 122 | 0.220 |
Why?
|
| Bone and Bones | 3 | 2022 | 2575 | 0.220 |
Why?
|
| Cell Nucleus | 6 | 2016 | 2969 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 3 | 2022 | 665 | 0.210 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2010 | 712 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2019 | 322 | 0.210 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2014 | 63 | 0.210 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 1401 | 0.210 |
Why?
|
| Receptors, Steroid | 1 | 2022 | 155 | 0.210 |
Why?
|
| Osteolysis, Essential | 2 | 2015 | 30 | 0.210 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 2734 | 0.210 |
Why?
|
| Bone Density Conservation Agents | 2 | 2021 | 773 | 0.210 |
Why?
|
| Hemangioendothelioma | 2 | 2016 | 121 | 0.210 |
Why?
|
| Leiomyoma | 3 | 2023 | 730 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2023 | 2948 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2018 | 35421 | 0.200 |
Why?
|
| Child, Preschool | 15 | 2023 | 41006 | 0.200 |
Why?
|
| Vitamin E | 2 | 2018 | 869 | 0.200 |
Why?
|
| Pathology, Surgical | 2 | 2014 | 155 | 0.200 |
Why?
|
| Vimentin | 4 | 2013 | 261 | 0.200 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.200 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 100 | 0.190 |
Why?
|
| Kidney Neoplasms | 4 | 2015 | 4262 | 0.190 |
Why?
|
| Genes, Neoplasm | 2 | 2014 | 376 | 0.190 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 2000 | 83 | 0.190 |
Why?
|
| Hyaline Cartilage | 1 | 2020 | 10 | 0.190 |
Why?
|
| Zebrafish | 4 | 2018 | 2994 | 0.190 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2020 | 255 | 0.190 |
Why?
|
| Child | 32 | 2023 | 77709 | 0.190 |
Why?
|
| Melanoma | 2 | 2022 | 5510 | 0.190 |
Why?
|
| Treatment Outcome | 24 | 2023 | 63114 | 0.180 |
Why?
|
| Histones | 3 | 2020 | 2599 | 0.180 |
Why?
|
| Microscopy, Electron | 7 | 2003 | 2645 | 0.180 |
Why?
|
| Predictive Value of Tests | 8 | 2019 | 15076 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2023 | 8428 | 0.180 |
Why?
|
| Homeodomain Proteins | 3 | 2021 | 2421 | 0.180 |
Why?
|
| Angiofibroma | 2 | 2001 | 68 | 0.180 |
Why?
|
| Vaginal Neoplasms | 2 | 2001 | 106 | 0.180 |
Why?
|
| DNA Mutational Analysis | 5 | 2018 | 4186 | 0.180 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2021 | 150 | 0.170 |
Why?
|
| Muscle Cells | 1 | 2020 | 197 | 0.170 |
Why?
|
| Florida | 1 | 2020 | 435 | 0.170 |
Why?
|
| Neurofibroma | 1 | 1999 | 106 | 0.170 |
Why?
|
| Mesothelioma | 2 | 2022 | 818 | 0.170 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 670 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2018 | 20129 | 0.170 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2019 | 97 | 0.170 |
Why?
|
| Adenoma | 3 | 2022 | 2174 | 0.160 |
Why?
|
| Myofibroblasts | 1 | 2020 | 222 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4931 | 0.160 |
Why?
|
| Skull Neoplasms | 1 | 2019 | 173 | 0.160 |
Why?
|
| Genes, Retinoblastoma | 1 | 1998 | 136 | 0.160 |
Why?
|
| Materials Testing | 2 | 2018 | 867 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 1142 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 462 | 0.160 |
Why?
|
| Hemangioendothelioma, Epithelioid | 2 | 2013 | 54 | 0.160 |
Why?
|
| Facial Bones | 1 | 2019 | 201 | 0.160 |
Why?
|
| Peroxides | 1 | 2018 | 74 | 0.160 |
Why?
|
| Mesoderm | 1 | 2001 | 686 | 0.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 514 | 0.150 |
Why?
|
| Photons | 2 | 2014 | 588 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2019 | 230 | 0.150 |
Why?
|
| Hyperplasia | 1 | 2021 | 1185 | 0.150 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 294 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1038 | 0.150 |
Why?
|
| RANK Ligand | 1 | 2019 | 326 | 0.150 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 260 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2003 | 990 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 6 | 2001 | 1799 | 0.150 |
Why?
|
| Muscle Neoplasms | 1 | 1998 | 139 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2002 | 556 | 0.150 |
Why?
|
| Myofibroma | 1 | 2017 | 50 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 498 | 0.150 |
Why?
|
| Lumbar Vertebrae | 3 | 2015 | 1848 | 0.140 |
Why?
|
| Fibroma, Desmoplastic | 1 | 1996 | 6 | 0.140 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2016 | 54 | 0.140 |
Why?
|
| Neoplasm Proteins | 6 | 2021 | 3703 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 241 | 0.140 |
Why?
|
| Sclerosis | 2 | 2014 | 213 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2018 | 199 | 0.140 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2017 | 61 | 0.140 |
Why?
|
| T-Box Domain Proteins | 2 | 2023 | 471 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 5853 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 504 | 0.140 |
Why?
|
| Smooth Muscle Tumor | 1 | 1996 | 67 | 0.130 |
Why?
|
| Neoplasm, Residual | 4 | 2014 | 973 | 0.130 |
Why?
|
| Stapes | 1 | 2015 | 88 | 0.130 |
Why?
|
| Lipomatosis | 1 | 2016 | 112 | 0.130 |
Why?
|
| Gene Amplification | 1 | 2020 | 1063 | 0.130 |
Why?
|
| Osteomyelitis | 2 | 2016 | 402 | 0.130 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 136 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2021 | 1381 | 0.130 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2017 | 298 | 0.130 |
Why?
|
| Mandibular Diseases | 1 | 2016 | 119 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 250 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2021 | 1166 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2012 | 0.130 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 581 | 0.130 |
Why?
|
| Intestines | 2 | 2016 | 1924 | 0.130 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2015 | 95 | 0.130 |
Why?
|
| Amyloidosis | 1 | 2021 | 795 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.120 |
Why?
|
| Repressor Proteins | 4 | 2022 | 3023 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4751 | 0.120 |
Why?
|
| MicroRNAs | 3 | 2019 | 3752 | 0.120 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2018 | 1094 | 0.120 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 44 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 7 | 2015 | 1770 | 0.120 |
Why?
|
| Fibrous Dysplasia, Monostotic | 1 | 2014 | 8 | 0.120 |
Why?
|
| Retrospective Studies | 26 | 2021 | 77449 | 0.120 |
Why?
|
| Thigh | 1 | 1995 | 247 | 0.120 |
Why?
|
| Telepathology | 1 | 2014 | 76 | 0.120 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2013 | 26 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 5867 | 0.120 |
Why?
|
| Knee | 1 | 1995 | 274 | 0.120 |
Why?
|
| Fibrosis | 4 | 2018 | 2029 | 0.120 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 1005 | 0.120 |
Why?
|
| Cecal Neoplasms | 1 | 1993 | 29 | 0.120 |
Why?
|
| Telomerase | 1 | 2019 | 730 | 0.120 |
Why?
|
| Limb Salvage | 1 | 2016 | 433 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2010 | 2038 | 0.120 |
Why?
|
| Vulvar Diseases | 2 | 2008 | 61 | 0.110 |
Why?
|
| Fetal Proteins | 1 | 2013 | 94 | 0.110 |
Why?
|
| Survival Rate | 9 | 2019 | 12788 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 3616 | 0.110 |
Why?
|
| Ossification, Heterotopic | 2 | 2009 | 239 | 0.110 |
Why?
|
| Shoulder | 1 | 1995 | 299 | 0.110 |
Why?
|
| Debridement | 1 | 2016 | 492 | 0.110 |
Why?
|
| Mast-Cell Sarcoma | 1 | 2012 | 47 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 1376 | 0.110 |
Why?
|
| Histiocytes | 2 | 2010 | 103 | 0.110 |
Why?
|
| Membrane Proteins | 4 | 2018 | 7880 | 0.110 |
Why?
|
| RNA | 2 | 2020 | 2749 | 0.110 |
Why?
|
| Radiotherapy, Conformal | 2 | 2014 | 548 | 0.110 |
Why?
|
| Myxosarcoma | 1 | 2012 | 15 | 0.110 |
Why?
|
| Furans | 1 | 2014 | 194 | 0.110 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 346 | 0.110 |
Why?
|
| Radiography | 5 | 2010 | 7023 | 0.110 |
Why?
|
| Radiotherapy Dosage | 7 | 2016 | 2879 | 0.110 |
Why?
|
| Combined Modality Therapy | 9 | 2016 | 8642 | 0.110 |
Why?
|
| Appendix | 1 | 1993 | 110 | 0.110 |
Why?
|
| Fibronectins | 1 | 2016 | 726 | 0.110 |
Why?
|
| Intermediate Filaments | 2 | 2010 | 175 | 0.110 |
Why?
|
| Stem Cells | 3 | 2016 | 3567 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 351 | 0.110 |
Why?
|
| Mesentery | 2 | 2022 | 205 | 0.100 |
Why?
|
| Osteolysis | 1 | 2014 | 270 | 0.100 |
Why?
|
| Remote Consultation | 1 | 2014 | 238 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 99 | 0.100 |
Why?
|
| Terminology as Topic | 2 | 1996 | 1547 | 0.100 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 16689 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2015 | 3143 | 0.100 |
Why?
|
| Antineoplastic Agents | 7 | 2019 | 13695 | 0.100 |
Why?
|
| Arthroplasty, Replacement | 2 | 2018 | 339 | 0.100 |
Why?
|
| Jaw Neoplasms | 1 | 2012 | 70 | 0.100 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 2011 | 15 | 0.100 |
Why?
|
| Necrosis | 2 | 2014 | 1643 | 0.100 |
Why?
|
| Follow-Up Studies | 15 | 2023 | 39050 | 0.100 |
Why?
|
| Thyroid Function Tests | 1 | 2012 | 286 | 0.100 |
Why?
|
| Joint Loose Bodies | 1 | 2011 | 19 | 0.100 |
Why?
|
| Hemosiderin | 1 | 2011 | 43 | 0.100 |
Why?
|
| Muscle Development | 1 | 2013 | 271 | 0.100 |
Why?
|
| Placenta | 1 | 2020 | 1698 | 0.100 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2011 | 34 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2015 | 596 | 0.100 |
Why?
|
| Temporal Bone | 1 | 2015 | 661 | 0.100 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2011 | 133 | 0.100 |
Why?
|
| Pelvis | 1 | 2015 | 730 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2013 | 602 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 1993 | 506 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 658 | 0.100 |
Why?
|
| Oncogenes | 2 | 2014 | 1265 | 0.090 |
Why?
|
| Maxillary Neoplasms | 1 | 2010 | 45 | 0.090 |
Why?
|
| Antioxidants | 1 | 2018 | 1663 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2021 | 2948 | 0.090 |
Why?
|
| Ankle | 1 | 2013 | 327 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1941 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 18029 | 0.090 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 74 | 0.090 |
Why?
|
| Cytoplasmic Structures | 1 | 2010 | 21 | 0.090 |
Why?
|
| Desmosomes | 1 | 2010 | 73 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 578 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 635 | 0.090 |
Why?
|
| Fatal Outcome | 4 | 2006 | 1850 | 0.090 |
Why?
|
| Thyroiditis | 1 | 2010 | 85 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 3772 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2013 | 1252 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2915 | 0.090 |
Why?
|
| Crystallization | 1 | 2011 | 524 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 314 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 223 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1861 | 0.090 |
Why?
|
| Phenotype | 4 | 2020 | 16365 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2018 | 6538 | 0.090 |
Why?
|
| Appendiceal Neoplasms | 1 | 1991 | 146 | 0.090 |
Why?
|
| Tumor Burden | 4 | 2020 | 1915 | 0.090 |
Why?
|
| Radiology | 1 | 2023 | 2100 | 0.090 |
Why?
|
| Histone Acetyltransferases | 1 | 2011 | 336 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1692 | 0.090 |
Why?
|
| Synovitis | 1 | 2011 | 209 | 0.090 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1999 | 335 | 0.080 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 334 | 0.080 |
Why?
|
| beta Catenin | 3 | 2023 | 1059 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2018 | 23403 | 0.080 |
Why?
|
| Immune Tolerance | 3 | 2003 | 2258 | 0.080 |
Why?
|
| Spinal Diseases | 1 | 2014 | 538 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 1855 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 776 | 0.080 |
Why?
|
| Genotype | 2 | 2013 | 12951 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 1 | 2009 | 146 | 0.080 |
Why?
|
| Adipocytes | 1 | 1995 | 1184 | 0.080 |
Why?
|
| Paranasal Sinuses | 1 | 2011 | 250 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2014 | 9438 | 0.080 |
Why?
|
| Stromal Cells | 3 | 2012 | 1355 | 0.080 |
Why?
|
| Organelles | 2 | 2001 | 264 | 0.080 |
Why?
|
| Infant | 6 | 2023 | 35136 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 1993 | 1758 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2011 | 835 | 0.080 |
Why?
|
| Neoplasm Staging | 7 | 2023 | 11031 | 0.080 |
Why?
|
| Cell Proliferation | 6 | 2018 | 10481 | 0.080 |
Why?
|
| Respiratory System | 1 | 2011 | 557 | 0.080 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 769 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2938 | 0.080 |
Why?
|
| Cell Count | 3 | 2018 | 1856 | 0.070 |
Why?
|
| Boston | 1 | 2020 | 9313 | 0.070 |
Why?
|
| Inclusion Bodies | 1 | 2008 | 279 | 0.070 |
Why?
|
| Antigens, CD34 | 2 | 1999 | 657 | 0.070 |
Why?
|
| Lymphangiosarcoma | 1 | 2006 | 13 | 0.070 |
Why?
|
| Immobilization | 1 | 2008 | 236 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2010 | 379 | 0.070 |
Why?
|
| Neoplasm Metastasis | 5 | 2018 | 4851 | 0.070 |
Why?
|
| Amiodarone | 1 | 2008 | 212 | 0.070 |
Why?
|
| Doxorubicin | 5 | 2014 | 2234 | 0.070 |
Why?
|
| Hamartoma | 1 | 2009 | 238 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 1813 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2011 | 4161 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 643 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2011 | 541 | 0.070 |
Why?
|
| Tendons | 1 | 2011 | 548 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2014 | 1248 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2006 | 251 | 0.070 |
Why?
|
| Muscles | 2 | 2009 | 1614 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 1206 | 0.070 |
Why?
|
| Survival Analysis | 5 | 2018 | 10252 | 0.070 |
Why?
|
| Low Back Pain | 1 | 2014 | 956 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 873 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2018 | 2085 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 4034 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2014 | 2942 | 0.060 |
Why?
|
| Chondrocytes | 2 | 2001 | 804 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 2503 | 0.060 |
Why?
|
| Animals | 23 | 2019 | 168757 | 0.060 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2009 | 709 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2148 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17446 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2008 | 789 | 0.060 |
Why?
|
| Edema | 1 | 2008 | 789 | 0.060 |
Why?
|
| Gout | 1 | 2011 | 573 | 0.060 |
Why?
|
| Lung Neoplasms | 6 | 2021 | 13102 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2541 | 0.060 |
Why?
|
| Epithelium | 2 | 2001 | 1679 | 0.060 |
Why?
|
| Hindlimb | 2 | 2003 | 504 | 0.060 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 2001 | 109 | 0.060 |
Why?
|
| Simplexvirus | 1 | 2007 | 802 | 0.060 |
Why?
|
| Rabbits | 3 | 2018 | 4894 | 0.060 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2003 | 22 | 0.060 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 806 | 0.060 |
Why?
|
| Hysterectomy | 2 | 2020 | 927 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 1988 | 0.060 |
Why?
|
| Neoplasms, Fibrous Tissue | 1 | 2003 | 25 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.060 |
Why?
|
| Time Factors | 7 | 2016 | 40075 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2022 | 36 | 0.060 |
Why?
|
| Cell Division | 4 | 2012 | 4568 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1146 | 0.050 |
Why?
|
| Mediastinum | 1 | 2023 | 267 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2015 | 5021 | 0.050 |
Why?
|
| Pyridines | 1 | 2014 | 2825 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2022 | 202 | 0.050 |
Why?
|
| Oncolytic Virotherapy | 1 | 2007 | 498 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2012 | 3479 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3327 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1257 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 5 | 2014 | 6314 | 0.050 |
Why?
|
| Isochromosomes | 1 | 2000 | 16 | 0.050 |
Why?
|
| Lipids | 1 | 2012 | 3305 | 0.050 |
Why?
|
| Omentum | 1 | 2002 | 170 | 0.050 |
Why?
|
| Cisplatin | 3 | 2014 | 1662 | 0.050 |
Why?
|
| beta 2-Microglobulin | 1 | 2021 | 315 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1839 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2001 | 130 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2001 | 2187 | 0.050 |
Why?
|
| Fasciitis | 2 | 2000 | 65 | 0.050 |
Why?
|
| Curettage | 1 | 2020 | 73 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2001 | 203 | 0.050 |
Why?
|
| Skull Base | 1 | 2023 | 306 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2012 | 11524 | 0.050 |
Why?
|
| Skin Transplantation | 2 | 2003 | 1074 | 0.050 |
Why?
|
| Metaplasia | 1 | 2001 | 313 | 0.050 |
Why?
|
| Cytogenetic Analysis | 2 | 2011 | 295 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 437 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3507 | 0.050 |
Why?
|
| Sirolimus | 3 | 2013 | 1564 | 0.050 |
Why?
|
| Ulna | 1 | 2001 | 133 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2014 | 890 | 0.040 |
Why?
|
| Hyalin | 1 | 1999 | 37 | 0.040 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 553 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15519 | 0.040 |
Why?
|
| Chimera | 1 | 2001 | 485 | 0.040 |
Why?
|
| Proteins | 2 | 2012 | 6103 | 0.040 |
Why?
|
| Recurrence | 3 | 2022 | 8340 | 0.040 |
Why?
|
| Genes, p16 | 1 | 1999 | 157 | 0.040 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 175 | 0.040 |
Why?
|
| Mandible | 1 | 2004 | 740 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 644 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2001 | 546 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6365 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2001 | 175 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1998 | 124 | 0.040 |
Why?
|
| Syndrome | 3 | 2015 | 3251 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 2019 | 321 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2013 | 1549 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2014 | 2109 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 1886 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 824 | 0.040 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 1997 | 21 | 0.040 |
Why?
|
| Glucose | 1 | 2010 | 4397 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 164 | 0.040 |
Why?
|
| Endometrium | 1 | 2001 | 424 | 0.040 |
Why?
|
| Models, Animal | 2 | 2003 | 2171 | 0.040 |
Why?
|
| Protons | 1 | 2023 | 1127 | 0.040 |
Why?
|
| Wilms Tumor | 1 | 2000 | 373 | 0.040 |
Why?
|
| Tomography | 1 | 1999 | 390 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2014 | 40561 | 0.040 |
Why?
|
| Buttocks | 1 | 1997 | 110 | 0.040 |
Why?
|
| Random Allocation | 2 | 2014 | 2429 | 0.040 |
Why?
|
| Mitochondria | 1 | 2010 | 3520 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 6171 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2018 | 211 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2010 | 730 | 0.040 |
Why?
|
| Mice | 10 | 2019 | 81183 | 0.040 |
Why?
|
| Vacuoles | 2 | 2012 | 230 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 1997 | 166 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2022 | 4286 | 0.040 |
Why?
|
| Radiotherapy | 2 | 2008 | 1533 | 0.040 |
Why?
|
| Amyloid | 1 | 2021 | 795 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2000 | 934 | 0.040 |
Why?
|
| DNA | 2 | 2022 | 7301 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 809 | 0.030 |
Why?
|
| PPAR delta | 1 | 2016 | 43 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1998 | 694 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 684 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12354 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 862 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2018 | 2255 | 0.030 |
Why?
|
| Hand | 1 | 2021 | 884 | 0.030 |
Why?
|
| Ovariectomy | 1 | 1998 | 661 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2020 | 689 | 0.030 |
Why?
|
| Genes, APC | 1 | 2016 | 159 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2505 | 0.030 |
Why?
|
| Lymphokines | 1 | 1998 | 949 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 2000 | 607 | 0.030 |
Why?
|
| Swine, Miniature | 3 | 2002 | 961 | 0.030 |
Why?
|
| Pain Measurement | 2 | 2016 | 3420 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1998 | 538 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2015 | 166 | 0.030 |
Why?
|
| Karyotyping | 2 | 2011 | 1243 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1998 | 671 | 0.030 |
Why?
|
| Hearing Loss, Conductive | 1 | 2015 | 158 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 1119 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1998 | 466 | 0.030 |
Why?
|
| Binding Sites | 1 | 2023 | 6114 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 2765 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1117 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1785 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2013 | 121 | 0.030 |
Why?
|
| Transplantation, Homologous | 4 | 2003 | 4776 | 0.030 |
Why?
|
| Ploidies | 1 | 1993 | 281 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2437 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 501 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 215 | 0.030 |
Why?
|
| Base Sequence | 2 | 2014 | 12797 | 0.030 |
Why?
|
| Mesna | 1 | 2012 | 66 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2013 | 117 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2001 | 2617 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2014 | 320 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 17 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2022 | 2924 | 0.030 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1999 | 808 | 0.030 |
Why?
|
| Incidence | 4 | 2015 | 20947 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 9274 | 0.030 |
Why?
|
| Neurofibrillary Tangles | 1 | 1995 | 439 | 0.030 |
Why?
|
| S Phase | 1 | 1993 | 423 | 0.030 |
Why?
|
| Ifosfamide | 1 | 2012 | 228 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 1786 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 21827 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 964 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 428 | 0.030 |
Why?
|
| Reference Values | 1 | 1999 | 4982 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2018 | 1354 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1504 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2002 | 5974 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2021 | 2504 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2440 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2016 | 729 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 3610 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 1996 | 1097 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 315 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 1999 | 1095 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 1998 | 1063 | 0.020 |
Why?
|
| Iceland | 1 | 1991 | 183 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2934 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3462 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2016 | 2297 | 0.020 |
Why?
|
| Transfection | 1 | 2019 | 5892 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 434 | 0.020 |
Why?
|
| Obesity | 2 | 2016 | 12745 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 509 | 0.020 |
Why?
|
| Hemosiderosis | 1 | 2011 | 71 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2265 | 0.020 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 435 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 277 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3479 | 0.020 |
Why?
|
| Lymphoma | 1 | 1999 | 1877 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 755 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3647 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 1387 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 879 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2014 | 646 | 0.020 |
Why?
|
| Leukemia | 1 | 2018 | 1511 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Organoids | 1 | 2016 | 701 | 0.020 |
Why?
|
| Dioxoles | 1 | 2010 | 104 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4204 | 0.020 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2010 | 91 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 643 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3505 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1642 | 0.020 |
Why?
|
| Workflow | 1 | 2014 | 847 | 0.020 |
Why?
|
| Xanthenes | 1 | 2009 | 73 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1792 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2012 | 302 | 0.020 |
Why?
|
| Decision Making | 1 | 2004 | 3887 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2012 | 566 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 903 | 0.020 |
Why?
|
| Gene Expression | 2 | 2014 | 7799 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14557 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2011 | 225 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 9734 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2014 | 5078 | 0.020 |
Why?
|
| Age of Onset | 1 | 2016 | 3271 | 0.020 |
Why?
|
| Polyradiculoneuropathy | 1 | 2008 | 64 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2011 | 313 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2010 | 520 | 0.020 |
Why?
|
| Lung Abscess | 1 | 2008 | 42 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 2008 | 0.020 |
Why?
|
| Oral Surgical Procedures | 1 | 2010 | 168 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1632 | 0.020 |
Why?
|
| Cadherins | 1 | 2013 | 907 | 0.020 |
Why?
|
| Pain | 1 | 2004 | 4986 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2009 | 195 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2010 | 585 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 188 | 0.020 |
Why?
|
| Osteotomy | 1 | 2014 | 822 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2010 | 5179 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 1999 | 1222 | 0.020 |
Why?
|
| Coccyx | 1 | 2007 | 12 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 944 | 0.020 |
Why?
|
| ras Proteins | 1 | 2013 | 1060 | 0.020 |
Why?
|
| Swine | 3 | 2003 | 5917 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2014 | 1486 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2007 | 90 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 675 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2012 | 648 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1379 | 0.020 |
Why?
|
| Relative Biological Effectiveness | 1 | 2008 | 323 | 0.020 |
Why?
|
| Keratin-19 | 1 | 2006 | 33 | 0.020 |
Why?
|
| Keratin-7 | 1 | 2006 | 57 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1999 | 2245 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2012 | 879 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 399 | 0.020 |
Why?
|
| Pregnancy | 2 | 2020 | 29144 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1660 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 3002 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 486 | 0.020 |
Why?
|
| Microvessels | 1 | 2010 | 544 | 0.020 |
Why?
|
| Chylothorax | 1 | 2006 | 84 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2886 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 18370 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2010 | 1880 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 728 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5256 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19905 | 0.020 |
Why?
|
| Skin Neoplasms | 3 | 2010 | 5686 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2161 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2011 | 2634 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3920 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2007 | 1144 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11124 | 0.020 |
Why?
|
| Vasculitis | 1 | 2008 | 519 | 0.020 |
Why?
|
| Longevity | 1 | 2012 | 1070 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2012 | 1158 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 21683 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2014 | 13033 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2011 | 2110 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 1198 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
| Regeneration | 1 | 2012 | 1485 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1999 | 3712 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 152 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1994 | 2647 | 0.010 |
Why?
|
| United States | 3 | 2016 | 69872 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1678 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2014 | 53288 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9386 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14722 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1995 | 3587 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2012 | 4026 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
| Graft Survival | 2 | 2002 | 3737 | 0.010 |
Why?
|
| Mitotic Index | 1 | 2001 | 172 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9146 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2250 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2002 | 292 | 0.010 |
Why?
|
| Neurofibromatosis 2 | 1 | 2004 | 380 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2022 | 23338 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2008 | 1809 | 0.010 |
Why?
|
| Software | 1 | 2014 | 4443 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4420 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 6234 | 0.010 |
Why?
|
| Histocompatibility | 1 | 2001 | 330 | 0.010 |
Why?
|
| Interferometry | 1 | 1999 | 100 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10397 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1999 | 25625 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 2016 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19229 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4215 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 2849 | 0.010 |
Why?
|
| Infrared Rays | 1 | 1999 | 249 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 786 | 0.010 |
Why?
|
| Microcirculation | 1 | 2003 | 1286 | 0.010 |
Why?
|
| Endothelium | 1 | 2001 | 778 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 4217 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2001 | 936 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 20822 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15295 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2000 | 566 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 462 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 2645 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9727 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5535 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 1998 | 267 | 0.010 |
Why?
|
| Skin | 2 | 2003 | 4364 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 2000 | 338 | 0.010 |
Why?
|
| Osteonecrosis | 1 | 1999 | 227 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13284 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1998 | 772 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2001 | 1663 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2327 | 0.010 |
Why?
|
| Cause of Death | 1 | 2007 | 3584 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 3689 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1998 | 318 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 25043 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1998 | 520 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1539 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1998 | 853 | 0.010 |
Why?
|
| Tooth Diseases | 1 | 1995 | 77 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1547 | 0.010 |
Why?
|
| Failure to Thrive | 1 | 1995 | 136 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1998 | 687 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6622 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 11727 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 1998 | 2088 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1995 | 409 | 0.010 |
Why?
|
| Palliative Care | 1 | 2007 | 3493 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 8863 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 1994 | 495 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4456 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1999 | 1401 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1994 | 455 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 1999 | 1288 | 0.010 |
Why?
|
| Musculoskeletal Diseases | 1 | 1995 | 581 | 0.010 |
Why?
|
| Face | 1 | 1995 | 994 | 0.010 |
Why?
|
| Catheterization | 1 | 1994 | 1470 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 7149 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3690 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4149 | 0.000 |
Why?
|
| Brain | 1 | 1995 | 26385 | 0.000 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1994 | 1261 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1998 | 3508 | 0.000 |
Why?
|
| Wound Healing | 1 | 1998 | 2785 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 4253 | 0.000 |
Why?
|
| Cell Line | 1 | 2001 | 15997 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1995 | 2149 | 0.000 |
Why?
|
| Dementia | 1 | 1995 | 2518 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1995 | 15165 | 0.000 |
Why?
|